Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Androgen therapy boosts muscle strength for older men

20.06.2002


A short course of hormone therapy appears to increase older men’s strength and may help seniors continue their everyday activities throughout the aging process, according to a study released today at the Endocrine Society’s 84th Annual Meeting.



Men over age 60 who took the androgen oxandrolone daily for 12 weeks had significantly stronger muscles in their upper and lower body than men who took a placebo, according to E. Todd Schroeder, Ph.D., postdoctoral fellow in the Department of Medicine at the Keck School of Medicine of USC and lead author of the study.

The findings suggest that supplemental androgen therapy might benefit older men who are prone to losing muscle mass-a process known as sarcopenia-as they age. Loss of leg power may interfere with basic activities, such as rising from a chair or walking up stairs. That, in turn, can lead to immobility, eroding independence and depression.


"Our findings are encouraging because a short course of treatment appears to increase muscle mass, strength and power, which can be augmented or maintained with subsequent resistance exercise," Schroeder says. "We are in the process of testing how well such effects are maintained following treatment and to what degree additional exercise improves these changes."

The challenges of maintaining the day-to-day health of seniors are mounting as fast as the nation is aging. By the year 2030, the number of people older than 65 will climb to 70 million in the U.S. alone.

Schroeder’s research aims to preserve the quality of life for many of these older men and women.

In his study, researchers monitored 32 men between 60 and 87 years old. About two-thirds of them were chosen at random to take 20 milligrams daily of oxandrolone, known by the trade name Oxandrin, while the rest took a placebo.

He and his colleagues measured the men’s muscle strength weekly by testing the maximum weight the men could lift with their arms and legs using equipment such as a leg press machine. They also measured muscle mass and other lean tissue using dual energy X-ray absorptiometry (commonly called a DEXA scan) and MRI (magnetic resonance imaging).

By the 12th week, men in the oxandrolone group had significantly increased maximal voluntary strength and power in their legs. Scientists have shown that maximal voluntary strength, which is measured by leg extension, is highly correlated with physical function among seniors. Maximal voluntary strength in the arms also was improved.

Study participants made most of their gains within the first six weeks, suggesting that six weeks of treatment may be enough to improve strength and power in older men, Schroeder says. Improvements in muscle strength were proportional with increases in muscle mass.

Androgens are linked to muscle mass in this way:

The body naturally uses the androgen testosterone to stimulate the creation of protein throughout the body, especially in muscle. Testosterone is the most powerful regulator of muscle. But levels of testosterone in the body decline over the course of a lifetime, and loss of muscle is linked to these decreased levels.

A semisynthetic agent (oxandrolone) that acts like testosterone can be used to supplement androgen activity in older persons with low levels of testosterone.

Since androgens increase the building of contractile muscle proteins- called actin and myosin- in the body, researchers believe they can help augment muscle mass that is lost during aging.

Skeletal muscle mass reportedly declines about 15 percent between the third and eighth decades of life, and as much as 30 percent afterward. And muscle seems to be lost in certain key areas such as the arms and thighs, which can especially hurt seniors’ ability to lift groceries, walk quickly, rise from a seated position and climb stairs.

Oxandralone was well-tolerated, Schroeder says, and separate findings from the study group indicated it also benefits body fat.

As people age, they not only lose muscle mass, but they gain fat around the middle, putting them at greater risk for cardiovascular disease and other problems. But in the men taking oxandrolone there was an increase in muscle mass both in the limbs and throughout the body, while the amount of fat carried in the trunk and throughout the body decreased.

Schroeder and colleagues plan to include women in future studies, since androgens also are important for maintaining bone mass and helping to prevent osteoporosis.

While many seniors may want to run to the doctor to ask for androgen therapy, only those seniors with initially low testosterone levels will benefit the most, Schroeder says.


Edward T. Schroeder, Dajun Qian, Yolanda Stewart, Carla Flores, Carmen Martinez, Michael Terk and Fred R. Sattler, "Muscle Strength and Power Changes with 12 Weeks of Oral Androgen Therapy in Older Adult Men," The Endocrine Society’s 84th Annual Meeting. Category: Aging. Presentation 1:45 p.m., June 22.


Jon Weiner | EurekAlert!

More articles from Health and Medicine:

nachricht Laser activated gold pyramids could deliver drugs, DNA into cells without harm
24.03.2017 | Harvard John A. Paulson School of Engineering and Applied Sciences

nachricht What does congenital Zika syndrome look like?
24.03.2017 | University of California - San Diego

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>